Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review

  • ID: 4278570
  • SWOT Analysis
  • 48 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Flatley Discovery Lab
  • Galapagos NV
  • IsoRay Inc
  • ProQR Therapeutics B.V.
  • Vertex
  • MORE
Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Proteostasis Therapeutics Inc (Proteostasis) is a developer of therapies that discovers and develops therapeutics for the treatment of diseases related to defects in protein folding, trafficking and clearance. The company’s portfolio spans drug candidates for cystic fibrosis, neurodegeneration and protein conformational diseases. Proteostasis employs Disease Relevant Translation platform that combines proteomics, genomics, and functional assays with medicinal chemistry and systems biology to discover novel drugs for disorders such as Alzheimer's disease, Huntington's disease, and Parkinson’s disease. PTI is headquartered in Cambridge, Massachusetts, the US.

Proteostasis Therapeutics Inc Key Recent Developments

Mar 14, 2018: Proteostasis Therapeutics Announces Fourth Quarter and Year-End 2017 Financial Results
Nov 14, 2017: Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update
Oct 31, 2017: Proteostasis Therapeutics Focuses on Research and Development of CF Drug Candidates and Astellas Pharma Collaboration Programs
Jul 31, 2017: Proteostasis Appoints Helen M. Boudreau as Chief Financial Officer
Jul 31, 2017: Proteostasis Therapeutics names Helen M. Boudreau as CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Flatley Discovery Lab
  • Galapagos NV
  • IsoRay Inc
  • ProQR Therapeutics B.V.
  • Vertex
  • MORE
Section 1 - About the Company
  • Proteostasis Therapeutics Inc - Key Facts
  • Proteostasis Therapeutics Inc - Key Employees
  • Proteostasis Therapeutics Inc - Key Employee Biographies
  • Proteostasis Therapeutics Inc - Major Products and Services
  • Proteostasis Therapeutics Inc - History
  • Proteostasis Therapeutics Inc - Company Statement
  • Proteostasis Therapeutics Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Proteostasis Therapeutics Inc - Business Description
  • R&D Overview
  • Proteostasis Therapeutics Inc - Corporate Strategy
  • Proteostasis Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Proteostasis Therapeutics Inc - Strengths
  • Proteostasis Therapeutics Inc - Weaknesses
  • Proteostasis Therapeutics Inc - Opportunities
  • Proteostasis Therapeutics Inc - Threats
  • Proteostasis Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Proteostasis Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 14, 2017: Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update
  • Oct 31, 2017: Proteostasis Therapeutics Focuses on Research and Development of CF Drug Candidates and Astellas Pharma Collaboration Programs
  • Jul 31, 2017: Proteostasis Appoints Helen M. Boudreau as Chief Financial Officer
  • Jun 02, 2017: Basilea names new member of its Extended Management Committee
  • Mar 30, 2017: Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update
  • Feb 27, 2017: Basilea proposes Dr. Nicole Onetto as new member of the Board of Directors
  • Feb 27, 2017: Basilea proposes Dr. Nicole Onetto as new member of the Board of Directors
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Proteostasis Therapeutics Inc, Key Facts
  • Proteostasis Therapeutics Inc, Key Employees
  • Proteostasis Therapeutics Inc, Key Employee Biographies
  • Proteostasis Therapeutics Inc, Major Products and Services
  • Proteostasis Therapeutics Inc, History
  • Proteostasis Therapeutics Inc, Key Competitors
  • Proteostasis Therapeutics Inc, Ratios based on current share price
  • Proteostasis Therapeutics Inc, Annual Ratios
  • Proteostasis Therapeutics Inc, Annual Ratios (Cont...1)
  • Proteostasis Therapeutics Inc, Interim Ratios
  • Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Proteostasis Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Proteostasis Therapeutics Inc, Performance Chart (2013 - 2017)
  • Proteostasis Therapeutics Inc, Ratio Charts
  • Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Proteostasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • ProQR Therapeutics B.V.
  • IsoRay Inc
  • AbbVie Inc
  • Flatley Discovery Lab
  • Galapagos NV
  • Vertex
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll